BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009;9:15. [PMID: 19220890 DOI: 10.1186/1471-230x-9-15] [Cited by in Crossref: 182] [Cited by in F6Publishing: 196] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Assalin HB, dos Santos A, de Souza AB, Bastos RG. Gut microbiome interventions in regenerative medicine. Nanotechnology and Regenerative Medicine 2023. [DOI: 10.1016/b978-0-323-90471-1.00006-2] [Reference Citation Analysis]
2 Luo M, Liu Q, Xiao L, Xiong L. Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation. J Health Popul Nutr 2022;41:21. [DOI: 10.1186/s41043-022-00302-0] [Reference Citation Analysis]
3 Wang X, Qi Y, Zheng H. Dietary Polyphenol, Gut Microbiota, and Health Benefits. Antioxidants (Basel) 2022;11:1212. [PMID: 35740109 DOI: 10.3390/antiox11061212] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
4 Shang X, E FF, Guo KL, Li YF, Zhao HL, Wang Y, Chen N, Nian T, Yang CQ, Yang KH, Li XX. Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials. Nutrients 2022;14:2482. [PMID: 35745212 DOI: 10.3390/nu14122482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Foster JP, Dahlen HG, Fijan S, Badawi N, Schmied V, Thornton C, Smith C, Psaila K. Probiotics for preventing and treating infant regurgitation: A systematic review and meta-analysis. Matern Child Nutr 2022;18:e13290. [PMID: 34908230 DOI: 10.1111/mcn.13290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dibba P, Kothari M, Grosman I. Prebiotics, Probiotics, and Dietary Supplements. Nutrition, Weight, and Digestive Health 2022. [DOI: 10.1007/978-3-030-94953-2_11] [Reference Citation Analysis]
7 Pratt C, Campbell MD. The Effect of Bifidobacterium on Reducing Symptomatic Abdominal Pain in Patients with Irritable Bowel Syndrome: A Systematic Review. Probiotics Antimicrob Proteins 2020;12:834-9. [PMID: 31741311 DOI: 10.1007/s12602-019-09609-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
8 Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S. Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome. South African Journal of Clinical Nutrition 2021;34:84-9. [DOI: 10.1080/16070658.2019.1697038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 2021;56:193-217. [PMID: 33538894 DOI: 10.1007/s00535-020-01746-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
10 Rispal J, Escaffit F, Trouche D. Chromatin Dynamics in Intestinal Epithelial Homeostasis: A Paradigm of Cell Fate Determination versus Cell Plasticity. Stem Cell Rev Rep 2020;16:1062-80. [PMID: 33051755 DOI: 10.1007/s12015-020-10055-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Farràs M, Martinez-Gili L, Portune K, Arranz S, Frost G, Tondo M, Blanco-Vaca F. Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity. Nutrients 2020;12:E2200. [PMID: 32718098 DOI: 10.3390/nu12082200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
12 Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med 2020;9:E685. [PMID: 32143424 DOI: 10.3390/jcm9030685] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
13 Gałązka P, Baska A, Kazik J, Leis K. Saccharomyces Cerevisiae Var. Boulardii In Irritable Bowel Syndrome. Postępy Mikrobiologii - Advancements of Microbiology 2020;59:39-47. [DOI: 10.21307/pm-2020.59.1.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Sasegbon A, Xiang X, Vasant DH, Hamdy S. Investigation of the brain–gut axis. Clinical and Basic Neurogastroenterology and Motility 2020. [DOI: 10.1016/b978-0-12-813037-7.00009-1] [Reference Citation Analysis]
15 Oh JH, Jang YS, Kang D, Chang DK, Min YW. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2019;11. [PMID: 31783597 DOI: 10.3390/nu11122887] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
16 Kamiński M, Skonieczna-Żydecka K, Łoniewski I, Koulaouzidis A, Marlicz W. Are probiotics useful in the treatment of chronic idiopathic constipation in adults? A review of existing systematic reviews, meta-analyses, and recommendations. Prz Gastroenterol 2020;15:103-18. [PMID: 32550942 DOI: 10.5114/pg.2019.86747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
17 Jensen AP, Bjørnvad CR. Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. J Vet Intern Med 2019;33:1849-64. [PMID: 31313372 DOI: 10.1111/jvim.15554] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
18 Tavakoli A, Flanagan JL. The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics? Antibiotics (Basel) 2019;8:E88. [PMID: 31262073 DOI: 10.3390/antibiotics8030088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
19 Capurso L. Thirty Years of Lactobacillus rhamnosus GG: A Review. J Clin Gastroenterol 2019;53 Suppl 1:S1-S41. [PMID: 30741841 DOI: 10.1097/MCG.0000000000001170] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 29.0] [Reference Citation Analysis]
20 Dalton A, Mermier C, Zuhl M. Exercise influence on the microbiome-gut-brain axis. Gut Microbes. 2019;10:555-568. [PMID: 30704343 DOI: 10.1080/19490976.2018.1562268] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
21 Trukhan DI, Goloshubina VV, Ivanova DS. Actual issues of diagnosis and treatment of irritable bowel syndrome. Med sov 2019. [DOI: 10.21518/2079-701x-2018-21-110-116] [Reference Citation Analysis]
22 Akpınar DD, Türköz BK. PROBIOTIC-HUMAN IMMUNE SYSTEM INTERACTIONS. Food Health 2019. [DOI: 10.3153/fh19027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Mukherjee S, Joardar N, Sengupta S, Sinha Babu SP. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. J Nutr Biochem 2018;61:111-28. [PMID: 30196243 DOI: 10.1016/j.jnutbio.2018.07.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
24 Armstrong LE, Lee EC, Armstrong EM. Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke. J Sports Med (Hindawi Publ Corp) 2018;2018:5724575. [PMID: 29850597 DOI: 10.1155/2018/5724575] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
25 Hungin APS, Mitchell CR, Whorwell P, Mulligan C, Cole O, Agréus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Seifert B, Wensaas KA, Winchester C, de Wit N; European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus. Aliment Pharmacol Ther 2018;47:1054-70. [PMID: 29460487 DOI: 10.1111/apt.14539] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 15.4] [Reference Citation Analysis]
26 Heath RD, Cockerell C, Mankoo R, Ibdah JA, Tahan V. Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders. North Clin Istanb. 2018;5:79-88. [PMID: 29607440 DOI: 10.14744/nci.2017.10692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
27 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
28 Winiarz D, Domańska K, Paluch K, Dorota Skrajnowska D. PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO. pps 2017;15:86-94. [DOI: 10.56782/pps.82] [Reference Citation Analysis]
29 Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 2017;117:93-107. [PMID: 28102115 DOI: 10.1017/S0007114516004037] [Cited by in Crossref: 240] [Cited by in F6Publishing: 244] [Article Influence: 40.0] [Reference Citation Analysis]
30 Sebastián Domingo JJ. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología (English Edition) 2017;40:417-429. [DOI: 10.1016/j.gastre.2016.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
31 Jadrešin O, Hojsak I, Mišak Z, Kekez AJ, Trbojević T, Ivković L, Kolaček S. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study. J Pediatr Gastroenterol Nutr 2017;64:925-9. [PMID: 27906800 DOI: 10.1097/MPG.0000000000001478] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
32 Valdovinos M, Montijo E, Abreu A, Heller S, González-garay A, Bacarreza D, Bielsa-fernández M, Bojórquez-ramos M, Bosques-padilla F, Burguete-garcía A, Carmona-sánchez R, Consuelo-sánchez A, Coss-adame E, Chávez-barrera J, de Ariño M, Flores-calderón J, Gómez-escudero O, González-huezo M, Icaza-chávez M, Larrosa-haro A, Morales-arámbula M, Murata C, Ramírez-mayans J, Remes-troche J, Rizo-robles T, Peláez-luna M, Toro-monjaraz E, Torre A, Urquidi-rivera M, Vázquez R, Yamamoto-furusho J, Guarner F. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017;82:156-178. [DOI: 10.1016/j.rgmxen.2017.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
34 El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_52] [Reference Citation Analysis]
35 Preidis GA, Chumpitazi BP, Shulman RJ. The Microbiome in Neurogastroenterology. Pediatric Neurogastroenterology 2017. [DOI: 10.1007/978-3-319-43268-7_5] [Reference Citation Analysis]
36 Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Clin Gastroenterol 2017;51:e5-e10. [PMID: 27306945 DOI: 10.1097/MCG.0000000000000528] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
37 Hod K, Ringel Y. Treatment of Functional Bowel Disorders With Prebiotics and Probiotics. The Microbiota in Gastrointestinal Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804024-9.00038-0] [Reference Citation Analysis]
38 Currò D, Ianiro G, Pecere S, Bibbò S, Cammarota G. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol 2017;174:1426-49. [PMID: 27696378 DOI: 10.1111/bph.13632] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 11.7] [Reference Citation Analysis]
39 Scarpignato C, Bertelé A, Tursi A. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease: Rationale and Current Evidence. J Clin Gastroenterol 2016;50 Suppl 1:S70-3. [PMID: 27622371 DOI: 10.1097/MCG.0000000000000641] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
40 Butel M, Waligora-dupriet A. Probiotics and prebiotics. The Human Microbiota and Chronic Disease 2016. [DOI: 10.1002/9781118982907.ch30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Nanayakkara WS, Skidmore PM, O'Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016;9:131-142. [PMID: 27382323 DOI: 10.2147/ceg.s86798] [Cited by in Crossref: 31] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
42 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
43 Michail S, Kenche H. Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome. Probiotics Antimicrob Proteins. 2011;3:1-7. [PMID: 22247743 DOI: 10.1007/s12602-010-9059-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
44 Marques T, Holster S, Wall R, König J, Brummer R, de Vos W. Correlating the Gut Microbiome to Health and Disease. The Gut-Brain Axis 2016. [DOI: 10.1016/b978-0-12-802304-4.00012-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Wong S. Phage Probiotics. Bacteriophage Applications - Historical Perspective and Future Potential 2016. [DOI: 10.1007/978-3-319-45791-8_5] [Reference Citation Analysis]
46 Infektionsschutz und spezielle Hygienemaßnahmen in klinischen Disziplinen. Krankenhaus- und Praxishygiene 2016. [DOI: 10.1016/b978-3-437-22312-9.00005-6] [Reference Citation Analysis]
47 Zuppa AA, Alighieri G, Scorrano A, Catenazzi P. Prebiotics and Probiotics in Infant Nutrition. Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00008-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Lembo A, Bollom A. Complementary and Alternative Medicine in Gastroenterology. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Syngai GG, Gopi R, Bharali R, Dey S, Lakshmanan GM, Ahmed G. Probiotics - the versatile functional food ingredients. J Food Sci Technol 2016;53:921-33. [PMID: 27162372 DOI: 10.1007/s13197-015-2011-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
50 Quigley EM. Probiotics in Irritable Bowel Syndrome: The Science and the Evidence. J Clin Gastroenterol 2015;49 Suppl 1:S60-4. [PMID: 26447967 DOI: 10.1097/MCG.0000000000000348] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
51 Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. [PMID: 26528128 DOI: 10.3389/fncel.2015.00392] [Cited by in Crossref: 468] [Cited by in F6Publishing: 536] [Article Influence: 58.5] [Reference Citation Analysis]
52 Mazurak N, Broelz E, Storr M, Enck P. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil. 2015;21:471-485. [PMID: 26351253 DOI: 10.5056/jnm15071] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
53 Spiller R, Pélerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, Jüsten P. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J. 2016;4:353-362. [PMID: 27403301 DOI: 10.1177/2050640615602571] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
54 Szilagyi A. Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases. Nutrients 2015;7:6751-79. [PMID: 26287234 DOI: 10.3390/nu7085309] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
55 Vicari E, La Vignera S, Castiglione R, Condorelli RA, Vicari LO, Calogero AE. Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3. Asian J Androl. 2014;16:735-739. [PMID: 24969056 DOI: 10.4103/1008-682x.131064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
56 Wibowo N, Mose JC, Karkata MK, Purwaka BT, Kristanto H, Chalid MT, Yusrawati Y, Sitepu M, Kaeng JJ, Bernolian N, Prasmusinto D, Irwinda R. The status of probiotics supplementation during pregnancy. Med J Indones 2015;24:120-30. [DOI: 10.13181/mji.v24i2.1223] [Reference Citation Analysis]
57 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
58 Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil 2015;27:705-16. [PMID: 25809913 DOI: 10.1111/nmo.12544] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
59 Hajela N, Ramakrishna BS, Nair GB, Abraham P, Gopalan S, Ganguly NK. Gut microbiome, gut function, and probiotics: Implications for health. Indian J Gastroenterol 2015;34:93-107. [PMID: 25917520 DOI: 10.1007/s12664-015-0547-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
60 Saneian H, Pourmoghaddas Z, Roohafza H, Gholamrezaei A. Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children. Gastroenterol Hepatol Bed Bench 2015;8:56-65. [PMID: 25584177] [Reference Citation Analysis]
61 Mönnikes H, Karaus M. Funktionelle Störungen des Dünn- und Dickdarms. Therapie-Handbuch Grundwerk inkl 6. Lfg. 2015. [DOI: 10.1016/b978-3-437-22107-1.50174-6] [Reference Citation Analysis]
62 Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50:11-30. [PMID: 25500976 DOI: 10.1007/s00535-014-1017-0] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 9.4] [Reference Citation Analysis]
63 Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189. [PMID: 25407511 DOI: 10.1186/s12876-014-0189-7] [Cited by in Crossref: 893] [Cited by in F6Publishing: 929] [Article Influence: 99.2] [Reference Citation Analysis]
64 Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Röcken C, Brasch J, Bethge J, Böttner M, Klose J, Milla PJ. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014;147:1012-20.e4. [PMID: 25083606 DOI: 10.1053/j.gastro.2014.07.046] [Cited by in Crossref: 203] [Cited by in F6Publishing: 207] [Article Influence: 22.6] [Reference Citation Analysis]
65 Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14. [PMID: 24912386 DOI: 10.1038/nrgastro.2014.66] [Cited by in Crossref: 4055] [Cited by in F6Publishing: 4008] [Article Influence: 450.6] [Reference Citation Analysis]
66 Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 2014;11:497-505. [PMID: 24751910 DOI: 10.1038/nrgastro.2014.40] [Cited by in Crossref: 229] [Cited by in F6Publishing: 220] [Article Influence: 25.4] [Reference Citation Analysis]
67 Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR. Irritable bowel syndrome: A concise review of current treatment concepts. World J Gastroenterol 2014; 20(27): 8796-8806 [PMID: 25083054 DOI: 10.3748/wjg.v20.i27.8796] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
68 Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8886-8897 [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
69 Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Aliment Pharmacol Ther 2014;40:51-62. [PMID: 24815298 DOI: 10.1111/apt.12787] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
70 Shavakhi A, Minakari M, Farzamnia S, Peykar MS, Taghipour G, Tayebi A, Hashemi H, Shavakhi S. The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial. Adv Biomed Res. 2014;3:140. [PMID: 25161987 DOI: 10.4103/2277-9175.135157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
71 Lahner E, Bellentani S, Bastiani RD, Tosetti C, Cicala M, Esposito G, Arullani P, Annibale B. A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders. United European Gastroenterol J. 2013;1:385-393. [PMID: 24917987 DOI: 10.1177/2050640613499567] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
72 Dupont HL. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 2014;39:1033-42. [PMID: 24665829 DOI: 10.1111/apt.12728] [Cited by in Crossref: 113] [Cited by in F6Publishing: 109] [Article Influence: 12.6] [Reference Citation Analysis]
73 Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014;146:1500-12. [PMID: 24583088 DOI: 10.1053/j.gastro.2014.02.037] [Cited by in Crossref: 283] [Cited by in F6Publishing: 295] [Article Influence: 31.4] [Reference Citation Analysis]
74 Hong SN, Rhee PL. Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol 2014; 20(10): 2470-2481 [PMID: 24627584 DOI: 10.3748/wjg.v20.i10.2470] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
75 Wang H, Gong J, Wang W, Long Y, Fu X, Fu Y, Qian W, Hou X. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One. 2014;9:e90153. [PMID: 24595218 DOI: 10.1371/journal.pone.0090153] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
76 König J, Brummer R. Modulation of the Gut Ecosystem in Irritable Bowel Syndrome. Pharma-Nutrition 2014. [DOI: 10.1007/978-3-319-06151-1_4] [Reference Citation Analysis]
77 Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench 2014;7:156-63. [PMID: 25120896] [Reference Citation Analysis]
78 Miller LE. Study design considerations for irritable bowel syndrome clinical trials. Ann Gastroenterol 2014;27:338-45. [PMID: 25330749] [Reference Citation Analysis]
79 Sheridan PO, Bindels LB, Saulnier DM, Reid G, Nova E, Holmgren K, O'Toole PW, Bunn J, Delzenne N, Scott KP. Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes 2014;5:74-82. [PMID: 24637591 DOI: 10.4161/gmic.27252] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
80 Akpınar H. Probiotics for Gastrointestinal Diseases. Probiotics and Prebiotics in Food, Nutrition and Health 2013. [DOI: 10.1201/b15561-16] [Reference Citation Analysis]
81 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2013;305:G529-41. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.7] [Reference Citation Analysis]
82 Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48:1127-35. [PMID: 23957590 DOI: 10.3109/00365521.2013.825314] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
83 Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Probiotics and irritable bowel syndrome. World J Gastroenterol 2013; 19(36): 5973-5980 [PMID: 24106397 DOI: 10.3748/wjg.v19.i36.5973] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
84 Bixquert M. Treatment of irritable bowel syndrome with probiotics: growing evidence. Indian J Med Res 2013;138:175-7. [PMID: 24056591] [Reference Citation Analysis]
85 Dapoigny M. Food-related Symptoms of Irritable Bowel Syndrome. Irritable Bowel Syndrome 2013. [DOI: 10.1002/9781118444689.ch8] [Reference Citation Analysis]
86 Amirimani B, Nikfam S, Albaji M, Vahedi S, Nasseri-Moghaddam S, Sharafkhah M, Ansari R, Vahedi H. Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial. Middle East J Dig Dis 2013;5:98-102. [PMID: 24829677] [Reference Citation Analysis]
87 Marteau P, Guyonnet D, Lafaye de Micheaux P, Gelu S. A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms. Neurogastroenterol Motil 2013;25:331-e252. [PMID: 23480238 DOI: 10.1111/nmo.12078] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
88 Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FD. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol. 2013;13:45. [PMID: 23496803 DOI: 10.1186/1471-230x-13-45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
89 Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013;29:184-9. [PMID: 23286925 DOI: 10.1097/MOG.0b013e32835d7bba] [Cited by in Crossref: 137] [Cited by in F6Publishing: 138] [Article Influence: 13.7] [Reference Citation Analysis]
90 El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional Gastrointestinal Disorders in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_46] [Reference Citation Analysis]
91 Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167] [Cited by in Crossref: 586] [Cited by in F6Publishing: 531] [Article Influence: 58.6] [Reference Citation Analysis]
92 Philpott H, Nandurkar S, Lubel J, Gibson PR. Alternative investigations for irritable bowel syndrome. J Gastroenterol Hepatol 2013;28:73-7. [PMID: 23033865 DOI: 10.1111/j.1440-1746.2012.07291.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
93 Halland M, Talley NJ. New treatments for IBS. Nat Rev Gastroenterol Hepatol 2013;10:13-23. [PMID: 23147658 DOI: 10.1038/nrgastro.2012.207] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
94 Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013;25:4-15. [PMID: 23279728 DOI: 10.1111/nmo.12046] [Cited by in Crossref: 163] [Cited by in F6Publishing: 165] [Article Influence: 16.3] [Reference Citation Analysis]
95 Haller D, Rimbach G, Grune T. Probiotika. Biofunktionalität der Lebensmittelinhaltsstoffe 2013. [DOI: 10.1007/978-3-642-29374-0_21] [Reference Citation Analysis]
96 Shojai M, Kazemnejad A, Zayeri F, Vahedi M. Application of semi-parametric single-index two-part regression and parametric two-part regression in estimation of the cost of functional gastrointestinal disorders. Gastroenterol Hepatol Bed Bench 2013;6:202-9. [PMID: 24834273] [Reference Citation Analysis]
97 Quigley EM. Probiotics in the management of functional bowel disorders: promise fulfilled? Gastroenterol Clin North Am 2012;41:805-19. [PMID: 23101688 DOI: 10.1016/j.gtc.2012.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
98 Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, Guarner F. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes. 2013;4:17-27. [PMID: 23202796 DOI: 10.4161/gmic.22973] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 13.2] [Reference Citation Analysis]
99 Boeckxstaens G, Corazziari ES, Mearin F, Tack J. IBS and the role of otilonium bromide. Int J Colorectal Dis. 2013;28:295-304. [PMID: 23178991 DOI: 10.1007/s00384-012-1598-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
100 Nelson AM, Walk ST, Taube S, Taniuchi M, Houpt ER, Wobus CE, Young VB. Disruption of the human gut microbiota following Norovirus infection. PLoS One 2012;7:e48224. [PMID: 23118957 DOI: 10.1371/journal.pone.0048224] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
101 Scaldaferri F, Pizzoferrato M, Pecere S, Forte F, Gasbarrini A. Bacterial flora as a cause or treatment of chronic diarrhea. Gastroenterol Clin North Am 2012;41:581-602. [PMID: 22917165 DOI: 10.1016/j.gtc.2012.06.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
102 Glickman-simon R, Basu Ray I. Acupuncture, Lactobacillus Traditional Chinese Herbal Medicine, Sanchitongtshu, and Honey. EXPLORE 2012;8:310-3. [DOI: 10.1016/j.explore.2012.06.009] [Reference Citation Analysis]
103 Farup PG, Jacobsen M, Ligaarden SC, Rudi K. Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome. Gastroenterol Res Pract 2012;2012:214102. [PMID: 22899904 DOI: 10.1155/2012/214102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
104 Korpela R, Niittynen L. Probiotics and irritable bowel syndrome. Microb Ecol Health Dis. 2012;23:18573. [PMID: 23990830 DOI: 10.3402/mehd.v23i0.18573] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
105 Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7:e34938. [PMID: 22529959 DOI: 10.1371/journal.pone.0034938] [Cited by in Crossref: 298] [Cited by in F6Publishing: 308] [Article Influence: 27.1] [Reference Citation Analysis]
106 Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr 2012;54:446-53. [PMID: 22027566 DOI: 10.1097/MPG.0b013e31823d34c3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
107 Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 2012;46:220-7. [PMID: 22157240 DOI: 10.1097/MCG.0b013e31823712b1] [Cited by in Crossref: 142] [Cited by in F6Publishing: 143] [Article Influence: 12.9] [Reference Citation Analysis]
108 Krammer H, Bluhm M. Probiotika bei Reizdarmsyndrom. Pharmazie in unserer Zeit 2012;41:134-140. [DOI: 10.1002/pauz.201100461] [Reference Citation Analysis]
109 Tang YH, Xu SC, Wu P. Irritable bowel syndrome and food allergy. Shijie Huaren Xiaohua Zazhi 2012; 20(5): 389-393 [DOI: 10.11569/wcjd.v20.i5.389] [Reference Citation Analysis]
110 Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther 2012;35:403-13. [PMID: 22225517 DOI: 10.1111/j.1365-2036.2011.04965.x] [Cited by in Crossref: 148] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
111 Cordina C, Shaikh I, Shrestha S, Camilleri-Brennan J. Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons. J Dig Dis 2011;12:489-96. [PMID: 22118700 DOI: 10.1111/j.1751-2980.2011.00534.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
112 Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable bowel syndrome--the main recommendations. Dtsch Arztebl Int. 2011;108:751-760. [PMID: 22163251 DOI: 10.3238/arztebl.2011.0751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
113 Ringel Y, Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2011;45 Suppl:S145-8. [PMID: 21992954 DOI: 10.1097/MCG.0b013e31822d32d3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
114 Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011;141:1782-91. [PMID: 21741921 DOI: 10.1053/j.gastro.2011.06.072] [Cited by in Crossref: 461] [Cited by in F6Publishing: 482] [Article Influence: 38.4] [Reference Citation Analysis]
115 Ko SJ, Ryu B, Kim J, Hong BG, Yeo I, Lee BJ, Lee JM, Park JW. Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial. Trials 2011;12:219. [PMID: 21978382 DOI: 10.1186/1745-6215-12-219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
116 Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-266. [PMID: 21860817 DOI: 10.5056/jnm.2011.17.3.252] [Cited by in Crossref: 122] [Cited by in F6Publishing: 137] [Article Influence: 10.2] [Reference Citation Analysis]
117 Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol 2011; 17(23): 2791-2800 [PMID: 21734786 DOI: 10.3748/wjg.v17.i23.2791] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
118 Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011;33:1302-10. [PMID: 21507030 DOI: 10.1111/j.1365-2036.2011.04665.x] [Cited by in Crossref: 135] [Cited by in F6Publishing: 133] [Article Influence: 11.3] [Reference Citation Analysis]
119 Bles H, Knuistingh Neven A. Probiotica bij irritable bowel syndrome. HUISARTS WETENSCHAP 2011;54:346-346. [DOI: 10.1007/s12445-011-0168-y] [Reference Citation Analysis]
120 Bischoff SC. 'Gut health': a new objective in medicine? BMC Med. 2011;9:24. [PMID: 21401922 DOI: 10.1186/1741-7015-9-24] [Cited by in Crossref: 171] [Cited by in F6Publishing: 187] [Article Influence: 14.3] [Reference Citation Analysis]
121 Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011;33:662-71. [PMID: 21251030 DOI: 10.1111/j.1365-2036.2010.04574.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 135] [Article Influence: 11.1] [Reference Citation Analysis]
122 Quigley EM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am 2011;40:207-22. [PMID: 21333908 DOI: 10.1016/j.gtc.2010.12.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
123 . Clinical Roundup: How Do You Treat Irritable Bowel Syndrome in Your Practice? Alternative and Complementary Therapies 2011;17:50-6. [DOI: 10.1089/act.2011.17110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
124 Erkrankungen des Dünn- und Dickdarms. Therapie–Handbuch Innere Medizin Sonderedition 2011⁄2012 2011. [DOI: 10.1016/b978-3-437-22702-8.50009-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Stevenson C, Blaauw R. Probiotics, with special emphasis on their role in the management of irritable bowel syndrome. South African Journal of Clinical Nutrition 2011;24:63-71. [DOI: 10.1080/16070658.2011.11734353] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
126 Karimi O, Peña AS. Probiotics in Clinical Practice as Therapeutics Against Enteric Disorders. Probiotic Bacteria and Enteric Infections 2011. [DOI: 10.1007/978-94-007-0386-5_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
127 Enck P, Junne F, Klosterhalfen S, Zipfel S, Martens U. Therapy options in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2010;22:1402-11. [PMID: 21389791 DOI: 10.1097/MEG.0b013e3283405a17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
128 Szajewska H. The Role of Meta-Analysis in the Evaluation of Clinical Trials on Probiotics. Probiotics and Health Claims 2010. [DOI: 10.1002/9781444329384.ch11] [Reference Citation Analysis]
129 Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 2010;10:134. [PMID: 21073731 DOI: 10.1186/1471-230x-10-134] [Cited by in Crossref: 157] [Cited by in F6Publishing: 162] [Article Influence: 12.1] [Reference Citation Analysis]
130 Lyra A, Krogius-Kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, Korpela R, Palva A. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol. 2010;10:110. [PMID: 20849659 DOI: 10.1186/1471-230x-10-110] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
131 Fujiya M, Kohgo Y. Novel perspectives in probiotic treatment: the efficacy and unveiled mechanisms of the physiological functions. Clin J Gastroenterol 2010;3:117-27. [PMID: 26190117 DOI: 10.1007/s12328-010-0154-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Hefner J, Klosterhalfen S, Martens U, Enck P. Psychische Faktoren gastrointestinaler Erkrankungen. Psychotherapeut 2010;55:203-208. [DOI: 10.1007/s00278-010-0744-9] [Reference Citation Analysis]
133 Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010;25:691-9. [PMID: 20074154 DOI: 10.1111/j.1440-1746.2009.06120.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 133] [Article Influence: 9.7] [Reference Citation Analysis]
134 Martens U, Enck P, Zieseniss E. Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci. 2010;8:Doc07. [PMID: 20234804 DOI: 10.3205/000096] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
135 Yan F, Polk DB. Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 2010;26:95-101. [PMID: 19952741 DOI: 10.1097/MOG.0b013e328335239a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 5.7] [Reference Citation Analysis]
136 Ghoshal UC, Park H, Gwee KA. Bugs and irritable bowel syndrome: The good, the bad and the ugly. J Gastroenterol Hepatol 2010;25:244-51. [PMID: 20074148 DOI: 10.1111/j.1440-1746.2009.06133.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
137 Morcos A, Dinan T, Quigley EM. Irritable bowel syndrome: role of food in pathogenesis and management. J Dig Dis 2009;10:237-46. [PMID: 19906102 DOI: 10.1111/j.1751-2980.2009.00392.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
138 Camilleri M, Mayer EA. Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes? Gastroenterology 2009;137:766-9. [PMID: 19643191 DOI: 10.1053/j.gastro.2009.07.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]